Clinical Study
Topical Administration of Pirfenidone Increases Healing of Chronic Diabetic Foot Ulcers: A Randomized Crossover Study
Table 3
Complete healing in the treatment groups.
| ā | All ulcers (%) | Pirfenidone (%) | Conventional (%) | |
| Ulcer healing < 8 weeks (35 ulcers at the beginning) | 13 (37.1) | 11 (52.4) | 2 (14.3) | 0.025 |
| Ulcer healing 8ā16 weeks (22 ulcers at the beginning) | 4 (17.4) | 4 (30.8) | 0 | 0.081 |
|
|